错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Unveiling Synthesis, Characterization, and Assessing Antimicrobial Efficacy of Quinoxaline-Based Oxazole Derivatives

  • Dharmesh K. Katariya,
  • Amita K. Vyas,
  • Pooja Bhanderi,
  • Priyank M. Shah,
  • Anjalee Khoyanee,
  • Bharat Mevada,
  • Manish Shah,
  • Ranjan Khunt

摘要

Abstract

Objective: The objective of this study is to investigate the metal catalyst-free synthesis and antimicrobial activity of quinoxaline-based oxazole derivatives (IVa–IVp), confirming their structure through spectral analyses. These compounds are evaluated for their in vitro antimicrobial efficacy against both Gram-negative and Gram-positive bacteria, suggesting their potential as therapeutic agents for treating microbial diseases, particularly bacterial infections. Methods: As a part of our efforts on determination of effect of antibacterial agents, in this study, we focused on the metal catalyst-free synthesis and antimicrobial activity of quinoxaline-based oxazole derivatives (IVa–IVp). Results and Discussion: The synthesized quinoxaline-based oxazole derivatives (IVa–IVp) exhibited significant antimicrobial activity against both Gram-negative (Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae) and Gram-positive (Staphylococcus aureus) bacteria. This suggests the potential of these compounds as therapeutic agents for microbial diseases, particularly in the treatment of bacterial infections. The presence of pharmacologically active groups in these derivatives further enhances their therapeutic relevance. These findings underscore the importance of exploring novel synthetic approaches and chemical structures in the development of antimicrobial agents with improved efficacy and potential clinical applications. Conclusions: The metal catalyst-free synthesis produced effective quinoxaline-based oxazole derivatives (IVa–IVp) with confirmed structures and significant antimicrobial activity against Gram-negative and Gram-positive bacteria, indicating their potential as therapeutic agents for bacterial infections, warranting further investigation for clinical application.